Skip to main content

Find Clinical Trials

Home
Conditions
Metaplasia

Clinical trial condition

Metaplasia

Explore clinical trials studying Metaplasia. Study availability and eligibility vary by location and protocol.

257 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Metaplasia trial results

Completed

Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)

NCT03929731

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +6 more
Locations: Singapore National Eye Centre Singapore

Tan Tock Seng Hospital Singapore

National University Hospital Singapore

View Trial Details

Completed

Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

NCT04278417

Conditions: Eye Diseases, Metaplasia, Neovascularization, Pathologic, +5 more
Locations: Retina Associates SW Tucson, Arizona, United States

Retina- Vitreous Assoc Medical Group Beverly Hills, California, United States

Retina Consultants of Orange County Fullerton, California, United States

Salehi Retina Institute Huntington Beach, California, United States

View all 120 locations

View Trial Details

Completed

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

NCT04679935

Conditions: Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +17 more
Locations: Novartis Investigative Site Regensburg, Bavaria, Germany

Novartis Investigative Site Frankfurt am Main, Hesse, Germany

Novartis Investigative Site Berlin, Germany

Novartis Investigative Site Bonn, Germany

View all 19 locations

View Trial Details

Completed

Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period

NCT07090044

Conditions: Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +18 more
Locations: The Retina Institute St Louis, Missouri, United States

View Trial Details

Completed

Extremity Thermographic Values in Individuals With Transtibial Amputation

NCT06258343

Conditions: Amputation, Amputation Stump, Amputation of Knee, +6 more
Locations: Senay Cerezci Duygu Ankara, Keçiören, Turkey (Türkiye)

View Trial Details

Completed

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

NCT04774926

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +16 more
Locations: Novartis Investigative Site Ancona, AN, Italy

Novartis Investigative Site Acquaviva delle Fonti, BA, Italy

Novartis Investigative Site Bologna, BO, Italy

Novartis Investigative Site Cagliari, CA, Italy

View all 20 locations

View Trial Details

Completed

A Study to Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

NCT02397954

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +7 more
Locations: Phoenix, Arizona, United States

View Trial Details

Completed

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

NCT05269966

Conditions: Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +22 more
Locations: Novartis Investigative Site Asarwa, Ahmedabad, India

Novartis Investigative Site Ahmedabad, Gujarat, India

Novartis Investigative Site Bangalore, Karnataka, India

Novartis Investigative Site Chennai, Tamil Nadu, India

View Trial Details

Completed

Efficacy and Safety of RTH258 Versus Aflibercept - Study 1

NCT02307682

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +6 more
Locations: Contact Alcon Call Center for Trial Locations Fort Worth, Texas, United States

View Trial Details

Completed

Efficacy and Safety of RTH258 Versus Aflibercept - Study 2

NCT02434328

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +6 more
Locations: Not specified

View Trial Details